SK

Stefanie Keil

SA Sanofi-Aventis: 17 patents #78 of 1,008Top 8%
SA Sanofi-Aventis: 16 patents #15 of 563Top 3%
SA Sanofi: 6 patents #253 of 1,881Top 15%
AG Aventis Pharma Deutschland Gmbh: 3 patents #103 of 418Top 25%
AP Aventis Pharmaceuticals: 3 patents #95 of 454Top 25%
📍 Hofheim, DE: #14 of 466 inventorsTop 4%
Overall (All Time): #73,800 of 4,157,543Top 2%
42
Patents All Time

Issued Patents All Time

Showing 1–25 of 42 patents

Patent #TitleCo-InventorsDate
8946212 Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals Matthias Urmann, Wolfgang Wendler, Maike Glien, Hans Matter, Eugen Falk 2015-02-03
8859494 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament Elisabeth Defossa, Viktoria Dietrich, Siegfried Stengelin, Andreas Herling, Guido Haschke +1 more 2014-10-14
8716317 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals Matthias Urmann, Wolfgang Wendler, Maike Glien, Hans Matter, Harry R. Munson, Jr. 2014-05-06
8648038 (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments Elisabeth Defossa, Viktoria Dietrich, Siegfried Stengelin, Andreas Herling, Guido Haschke +1 more 2014-02-11
8530413 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments Elisabeth Defossa, Viktoria Dietrich, Siegfried Stengelin, Andreas Herling, Guido Haschke +1 more 2013-09-10
8344004 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals Karl Schoenafinger, Matthias Urmann, Hans Matter, Maike Glien, Wolfgang Wendler 2013-01-01
8329725 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals Matthias Urmann, Wolfgang Wendler, Ulrike Wendler, Maike Glien, Hans Matter +1 more 2012-12-11
8207146 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical Elisabeth Defossa, Dieter Schmoll, Axel Dietrich, Johanna Kuhlmann-Gottke, Karl Engel 2012-06-26
8173674 Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals Matthias Urmann, Karl Schoenafinger, Wolfgang Wendler, Maike Glien, Hans-Ludwig Schaefer +1 more 2012-05-08
8048901 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals Jochen Goerlitzer, Heiner Glombik, Eugen Falk, Dirk Gretzke, Hans-Ludwig Schaefer +2 more 2011-11-01
8003677 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as SCD inhibitors Gerhard Zoller, Marc Dietrich Voss, Andreas Herling, Hans Matter 2011-08-23
7956077 2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes Heiner Glombik, Christian Stapper, Eugen Falk, Hans-Ludwig Schaefer, Wolfgang Wendler +1 more 2011-06-07
7910612 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use Karl Schoenafinger, Hans Matter, Matthias Urmann, Maike Glien, Wolfgang Wendler +2 more 2011-03-22
7872034 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals Christian Stapper, Heiner Glombik, Eugen Falk, Jochen Goerlitzer, Dirk Gretzke +2 more 2011-01-18
7872032 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof Daniel McGarry, Jochen Goerlitzer, Karen Chandross, Jean Merrill, Wolfgang Wendler 2011-01-18
7858647 N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use Hans Matter, Karl Schoenafinger, Matthias Urmann, Maike Glien, Wolfgang Wendler +2 more 2010-12-28
7851493 Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals Patrick Bernardelli, Matthias Urmann, Hans Matter, Wolfgang Wendler, Maike Glien +4 more 2010-12-14
7834030 Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof Patrick Bernardelli, Matthias Urmann, Hans Matter, Wolfgang Wendler, Maike Glien +2 more 2010-11-16
7772257 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use Karl Schoenafinger, Matthias Urmann, Hans Matter, Maike Glien, Wolfgang Wendler 2010-08-10
7732440 Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals Elisabeth Defossa, Karl Schoenafinger, Dieter Schmoll, Axel Deitrich, Johanna Kuhlmann-Gottke +1 more 2010-06-08
7732471 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof Christian Stapper, Heiner Glombik, Eugen Falk, Hans-Ludwig Schaefer, Wolfgang Wendler +1 more 2010-06-08
7709481 Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals Matthias Urmann, Patrick Bernardelli, Maike Glien, Wolfgang Wendler, Karen Chandross +1 more 2010-05-04
7709509 Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists Wolfgang Wendler, Maike Glien, Jochen Goerlitzer, Karen Chandross, Daniel McGarry +4 more 2010-05-04
7683181 Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof Karl Schoenafinger, Matthias Urmann, Hans Matter, Maike Glien, Wolfgang Wendler 2010-03-23
7655679 Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions Matthias Urmann, Maike Glien, Wolfgang Wendler, Karen Chandross, Lan-Ying Lee 2010-02-02